Phase 2 OCD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with OCD:
- You are between 18 and 65 years old
- You have been diagnosed with OCD
- At least one standard treatment for OCD has not worked for you in the past
- You are willing to fast before the main study session, not join other clinical trials during the study, and follow the study's medication procedures
- You are able to give your informed consent to participate
For healthy volunteers (people without OCD):
- You are between 18 and 65 years old
- You are able to give your informed consent to participate
Who may not be able to join:
For people with OCD:
- You have previously used or been exposed to the medications naltrexone or ketamine
- You have any current or past physical or mental health condition that the study doctor feels would make it unsafe for you to participate (confirm with trial site)
- You are pregnant, breastfeeding, or capable of becoming pregnant and are not using an effective form of birth control
- You have metal in your body that would make it unsafe for you to have an MRI scan
For healthy volunteers:
- You currently take or have ever taken medication for mental health conditions
- You are pregnant or breastfeeding
- You have metal in your body that would make it unsafe for you to have an MRI scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 6504972578
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.